184 related articles for article (PubMed ID: 8062493)
1. Population pharmacokinetics of vancomycin in neonates.
Seay RE; Brundage RC; Jensen PD; Schilling CG; Edgren BE
Clin Pharmacol Ther; 1994 Aug; 56(2):169-75. PubMed ID: 8062493
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.
Anderson BJ; Allegaert K; Van den Anker JN; Cossey V; Holford NH
Br J Clin Pharmacol; 2007 Jan; 63(1):75-84. PubMed ID: 16869817
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of vancomycin and AUC-guided dosing in Chinese neonates and young infants.
Chen Y; Wu D; Dong M; Zhu Y; Lu J; Li X; Chen C; Li Z
Eur J Clin Pharmacol; 2018 Jul; 74(7):921-930. PubMed ID: 29602981
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determination.
Lo YL; van Hasselt JG; Heng SC; Lim CT; Lee TC; Charles BG
Antimicrob Agents Chemother; 2010 Jun; 54(6):2626-32. PubMed ID: 20385872
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
Mehrotra N; Tang L; Phelps SJ; Meibohm B
Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of gentamicin in premature newborns.
García B; Barcia E; Pérez F; Molina IT
J Antimicrob Chemother; 2006 Aug; 58(2):372-9. PubMed ID: 16782742
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.
Marqués-Miñana MR; Saadeddin A; Peris JE
Br J Clin Pharmacol; 2010 Nov; 70(5):713-20. PubMed ID: 21039765
[TBL] [Abstract][Full Text] [Related]
10. Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
Nielsen EI; Sandström M; Honoré PH; Ewald U; Friberg LE
Clin Pharmacokinet; 2009; 48(4):253-63. PubMed ID: 19492870
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of midazolam in neonates.
Burtin P; Jacqz-Aigrain E; Girard P; Lenclen R; Magny JF; Betremieux P; Tehiry C; Desplanques L; Mussat P
Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):615-25. PubMed ID: 7995003
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
Kildoo CW; Lin LM; Gabriel MH; Folli HL; Modanlou HD
Dev Pharmacol Ther; 1989; 14(2):77-83. PubMed ID: 2630235
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates.
Fuchs A; Guidi M; Giannoni E; Werner D; Buclin T; Widmer N; Csajka C
Br J Clin Pharmacol; 2014 Nov; 78(5):1090-101. PubMed ID: 24938850
[TBL] [Abstract][Full Text] [Related]
14. Development and external evaluation of a population pharmacokinetic model for continuous and intermittent administration of vancomycin in neonates and infants using prospectively collected data.
Germovsek E; Osborne L; Gunaratnam F; Lounis SA; Busquets FB; Standing JF; Sinha AK
J Antimicrob Chemother; 2019 Apr; 74(4):1003-1011. PubMed ID: 30668696
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and dose optimization of vancomycin in neonates.
Lee SM; Yang S; Kang S; Chang MJ
Sci Rep; 2021 Mar; 11(1):6168. PubMed ID: 33731764
[TBL] [Abstract][Full Text] [Related]
17. Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis.
Goti V; Chaturvedula A; Fossler MJ; Mok S; Jacob JT
Ther Drug Monit; 2018 Apr; 40(2):212-221. PubMed ID: 29470227
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Kimura T; Sunakawa K; Matsuura N; Kubo H; Shimada S; Yago K
Antimicrob Agents Chemother; 2004 Apr; 48(4):1159-67. PubMed ID: 15047516
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation.
Moffett BS; Morris J; Galati M; Munoz F; Arikan AA
Pediatr Crit Care Med; 2018 Oct; 19(10):973-980. PubMed ID: 30063652
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]